期刊文献+

冠心病与感染性危险因子的关系 被引量:4

原文传递
导出
摘要 本文从细菌、病毒、衣原体极有可能是导致动脉粥样硬化(AS)和冠心病的感染性危险因子等角度,综述这些危险性因子与冠心病发生和发展的关系。
作者 刘正刚 尹岭
出处 《实用预防医学》 CAS 2010年第8期1710-1710,F0003,共2页 Practical Preventive Medicine
  • 相关文献

参考文献12

  • 1李建军,夏豪,李庚山.感染与冠心病的关系[J].心血管病学进展,1999,20(5):297-299. 被引量:20
  • 2Patel P, Menduall MA, Garfington D, et al. Association of Helieobaterpylon and chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors[ J ]. BMJ, 1995,311 : 711 - 714.
  • 3陈良海,李代渝,李刚,刘远厚,邓辉胜.幽门螺杆菌感染与冠心病的相关性研究[J].临床心血管病杂志,1999,15(4):156-158. 被引量:12
  • 4Melnick JL, Adam E, Debakey ME, et al. Possible role of eytomegalovirus in atherogensis[J ]. JAMA, 1990,263 : 2204 - 2211.
  • 5林立芳,沈晓丽,潘棱,颜光烈,浦晓东,胡锡衷.急性心梗患者人类巨细胞病毒感染研究[J].中国人兽共患病杂志,2000,16(6):117-117. 被引量:2
  • 6Speir E, Yu Z - X, Victor J, et al. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase - 2 in coronary artery smooth muscle cells[J ]. Circ Res, 1998,83 : 210 - 216.
  • 7Chiu B, Viira E, Tucker W, et al. Chlamydia pneumoniae cytomegalovirus, and herpes simplex vires in atherosclerosis of the carotid artey[J ]. Circule - tion, 1997,96 : 2144 - 2148.
  • 8李建军,黄从新,李庚山,等.冠心病患者血巨细胞病毒DNA检测意义初探[J].中国循环杂志,1998,(13):346.
  • 9卢敏,张梦玺,曹军香.肺炎衣原体感染与冠心病相互关系的研究[J].临床心血管病杂志,2001,17(7):313-314. 被引量:6
  • 10吴晓燕,魏兵,冯永堂,苗乃法,徐志伟.肺炎衣原体感染与冠心病关系的初步探讨[J].潍坊医学院学报,2002,24(2):101-103. 被引量:3

二级参考文献44

  • 1[2]Melnick JL, Adam E, Debakey ME. Possible role of cytomegalovirus in atherogenesis[J]. JAMA, 1990, 263: 2204~2209.
  • 2[3]Shimokawa H, Ito A, Fukumoto Y, et al. Chronic treatment with mterleukin-1 βinduces coroary intimal lesions and vasospastic responses inpigs in vivo. The role of platelet-derived growth factor [J]. J Clin Invest,1996,97:769~776.
  • 3[4]Visser MR, Vetcellatti GM. Herpes simple virus and atherosclerosis[J]. Eur Heart J,1994,14(suppl): 39.
  • 4[1]Schumacher A, Lerkerod AB. Chlamydia pneumonia serology: importance of methodology in patients with coronary heart disease and healthy individual[J]. J Clin Microbiol,2001,39(5): 1859.
  • 5[2]Bauriedel G, Welsch U, Likunga JA. Chlamydia pneumoniac in coronary plaques:increased detection with acute coronary syndrome[J]. Dtsch Med Wochenschr, 1999,124(13) :375.
  • 6[3]Aas S, Bartels C, Engel P. Endovascular presence of viable chlamydia pneumoniae is a common phenomenon in coronary artery disease[J]. J Am Coll Cardiol, 1998,31 (4): 827.
  • 7[4]Gieffers J, Fullgraf H, Jahn J. Chlamydia pneumoniae infection in circulating human monolytes is refractory to antibiotic treatment[J]. Circulation,2001,103(3) :351.
  • 8[5]Saikku P, Leinonen M. Chronic chlamydia pneumoniae infection as a risk factor for coronary heart disease in the helsinki heart study[J]. Ann Intern Med, 1992,16(4) :273.
  • 9[6]Eila Linnanm kE, Leinonen M. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease[J]. Circulation, 1993,87(4): 1130.
  • 10[7]Puolakkainen M, Kuo CC, Allan S. Serological response to chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plagues[J]. J Clin Microbiol ,1993 , 31( 8 ) : 2212 .

共引文献40

同被引文献41

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部